Iowa News

J&J Scores Phase III Victory in Major Depressive Disorder

Published: May 29, 2024 By Kate Goodwin Pictured: J&J’s building in Switzerland/iStock, yuelan J&J announced Wednesday its late-stage experimental drug seltorexant met all primary and secondary endpoints in a Phase III study of patients with major depressive […]

[adinserter block="2"]
No Picture
Illinois News

New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years

DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, today announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an […]

Illinois News

Homethrive Receives Vizient Contract for Caregiving Benefit

The contract offers hospitals and health systems a solution to prioritize the well-being of their employees NORTHBROOK, Ill., May 29, 2024 /PRNewswire/ — Homethrive, a high-tech, high-touch family caregiving support platform, has received a contract […]

[adinserter block="2"]
No Picture
Illinois News

Naveris to Present New Data Highlighting Clinical Utility of the NavDx® Test at the 2024 ASCO Annual Meeting

WALTHAM, Mass.–(BUSINESS WIRE)–Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced new data to be presented at The American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL from May […]

[adinserter block="2"]
Illinois News

Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Docetaxel Injection, USP Due to Potential Presence of Particulate Matter

SCHAUMBURG, Ill., May 28, 2024 /PRNewswire/ — Sagent Pharmaceuticals today announced the voluntary nationwide recall of two lots of Docetaxel Injection, USP (80 mg per 8 mL multi-dose vials and 160 mg per 16 mL […]